CA24657-1 - 0x000000000000360A

Study Number: CA24657
Group Number: 1
Study Requirement: Healthy Male and Female
Stipend: $2,480.00

Study Criteria:

  • Age: 19 - 55
  • BMI: 16 - 28
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat Hepatitis B.
  • Route of Administration: Oral
  • Blood Draws: 23

Study Schedule:

  • Schedule Type: Long Term
  • Study Length: One- 7 Night Stay & 2 Returns

Screening Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Monday 6/11/2018
Tuesday 6/12/2018

Doctor Exam Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Monday 6/11/2018
Tuesday 6/12/2018

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Sunday 6/24/2018 3:00:00 PM Sunday 7/1/2018 9:00:00 AM 1 Lincoln
Return Sunday 7/8/2018 7:30:00 AM Sunday 7/8/2018 8:30:00 AM 1 Lincoln
Return Sunday 7/15/2018 7:30:00 AM Sunday 7/15/2018 8:30:00 AM 1 Lincoln